1 completed, 1 recruiting, 1 terminated. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Serous Carcinoma: new trials by email Literature Review of Serous Carcinoma trials Research Report on Serous Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma Niraparib - Endometrial Carcinoma, Serous Carcinoma | Phase 2 | Recruiting | Shandong University | 83 | 2021-06-01 | 2024-01-05 |
| A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer External Beam Radiation, Niraparib, Vaginal high-dose rate brachytherapy - Endometrial Carcinoma, P53 Mutation | Phase 2 / Phase 3 | Terminated | University Health Network, Toronto | 11 | 2020-11-17 | 2025-08-12 |
| Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. Image-guided adjuvant pelvic radiotherapy - Endometrioid Adenocarcinoma, Serous Carcinoma | Not applicable | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 23 | 2020-08-26 | 2025-08-01 |
Cystadenocarcinoma, Serous (3) · Endometrial Neoplasms (2) · Adenocarcinoma, Clear Cell (1) · Carcinoma, Endometrioid (1) · Carcinosarcoma (1)
Adenocarcinoma (3) · Carcinoma (3) · Cystadenocarcinoma (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Cystic, Mucinous, and Serous (3) · Neoplasms, Glandular and Epithelial (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3)
niraparib (2)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Shandong University (1) · University Health Network, Toronto (1)
Canada (2) · China (1)
Amit Oza, MD (1) · David D'Souza, M.D. (1)